Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
08/2007
08/09/2007US20070185169 2-Mercapto-4,5-Diarylimidazole Derivatives and the use thereof as Cyclooxygenase Inhibitors
08/09/2007US20070185122 Use of efletirizine for treating persistent allergic rhinitis
08/09/2007US20070185112 Piperidine/piperazine-type inhibitors of p38 kinase
08/09/2007US20070185110 pollinosis, bronchial asthma, atopic dermatitis, urticaria; endometriosis and hysteromyoma
08/09/2007US20070185091 Bicyclic Heterocycles, Pharmaceutical Compositions Containing These Compounds, Their Use and Processes for Preparing Them
08/09/2007US20070185090 Muscarinic acetylchoine receptor antagonists
08/09/2007US20070185088 M3 muscarinic acetylchoine receptor antagonists
08/09/2007US20070185059 Antiallergic agents
08/09/2007US20070185048 ATP-binding cassette transporter polypeptide which regulates metabolism of triglycerides; treatment of obesity and eating disorders
08/09/2007US20070185011 Individual is not exposed to C1INH for longer than required, since levels of the C1INH more rapidly subsides after administration has stopped; side effect reduction
08/09/2007US20070184114 Formulation for topical non-invasive application in vivo
08/09/2007US20070184069 Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
08/09/2007US20070183983 Medical composition containing nf-kb decoy for treating and preventing respir atory diseases and method of using the same
08/09/2007US20070181124 Method and apparatus for dispensing inhalator medicament
08/09/2007CA2640454A1 Compounds and methods for modulating protein trafficking
08/09/2007CA2637083A1 Use of naphthyridine derivatives as medicaments
08/08/2007EP1816138A1 Cyclosporine analogue mixtures and their use as immunomodulating agents
08/08/2007EP1816123A1 Intermediates for the production of pharmaceutically active compounds
08/08/2007EP1815867A1 Combination drug for treating autoimmune disease
08/08/2007EP1815862A1 Isolated stromal cells for use in the tretment of diseases of the central nervous system
08/08/2007EP1708994B1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
08/08/2007EP1554264B1 Medicinal arylethanolamine compounds
08/08/2007EP1532111B1 2,5-disubstituted 3-mercaptopentanoic acid
08/08/2007EP1506202B1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
08/08/2007EP1487832B1 Micronized crystalline tiotropium bromide
08/08/2007EP1482938B1 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
08/08/2007EP1480671B1 Recombinant rsv virus expression systems and vaccines
08/08/2007EP1359902B1 Bimodal dry powder formulation for inhalation
08/08/2007EP1347979B1 Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands
08/08/2007EP1039804A4 Method for treating fibroproliferative disorders by inhibitors of protein hydroxylation
08/08/2007EP0706376B2 Anti-angiogenic compositions and methods of use
08/08/2007CN1330657C Novel piperidine and piperazine derivatives
08/08/2007CN1330654C Fused bicyclic pyrimidine derivatives
08/08/2007CN1330638C Substituted imidazolidine derivatives, their prepn., their use and pharmaceutical prepn. comprising them
08/08/2007CN1330391C Aerosol container for formulations of salmeterol xinafoate
08/08/2007CN1330352C Health care wine and preparation method
08/08/2007CN1330344C Medicinal composition for treating acute, chronic pharyngolaryngitis and its preparation method
08/08/2007CN1330329C Medicine composition for preventing and controlling respiratory tract virus and bacterial infection of birds and preparing method
08/08/2007CN1330322C Notoginseng throat nourishing lozenge and its preparation method
08/08/2007CN1330314C 西地碘口含片 West to iodine buccal tablets
08/08/2007CN1330306C Moxifloxaci gelatin capsule and preparation process thereof
08/08/2007CN1330296C Propolis soft capsule and its preparation method
08/08/2007CN101014708A Use of antisense oligonucleotides or sirna to suppress expression of eif-5a1
08/08/2007CN101014600A 6-(2-alkyl-phenyl) - pyrido[2,3-d] pyrimidines useful as proteine kinase inhibitors
08/08/2007CN101011584A Method for achieving persistent transgene expression
08/08/2007CN101011576A Compositions and methods for treating or preventing inflammatory diseases
08/08/2007CN101011555A Chinese medicine preparation for treating radioactive fibrosis and its preparation process
08/08/2007CN101011541A Chinese traditional medicine composition for treating influenza and quality controlling method thereof
08/08/2007CN101011536A Nose-ear health care traditional Chinese medicine preparation and stifling warm-wet therapy
08/08/2007CN101011529A Pharynx-clearing and throat-health-care medicament and its preparation
08/08/2007CN101011527A Improved preparation of Juhong pill, its preparation method and quality inspection method
08/08/2007CN101011526A Traditional Chinese medicine for treating cold and its preparing process
08/08/2007CN101011524A Capsule for treating cough
08/08/2007CN101011523A Externally applied plaster for relieving cough and removing the phlegm
08/08/2007CN101011494A Drop pills for treating asthma cough and preparation method thereof
08/08/2007CN101011477A Shangqing pills formula and its production process
08/08/2007CN101011458A Traditional Chinese medicine formulation for treating ulcer
08/08/2007CN101011440A Traditional Chinese medicine solid preparation and its preparing process and use
08/08/2007CN101011439A Collunarium or spraying preparation for treating nasal cavity inflammation and its preparation method
08/08/2007CN101011419A Bee glue preparation and its preparation method
08/08/2007CN101011417A Glucoprotein for the treatment of chronic obstructive pulmonary diseases
08/08/2007CN101011414A Improved lung-brain composition medicine
08/08/2007CN101011207A Health care medicated pillow
08/08/2007CN101011185A Hybrid health cigarette
08/08/2007CN101011184A Tobacco substitution chrysanthemum health cigarette
08/08/2007CN101011154A Cactus beverage with health care function for lung
08/08/2007CN101011097A Herb tea compositions
08/07/2007US7253295 Chloride channel opener
08/07/2007US7253284 Chemical compounds
08/07/2007US7253281 2-(9-bromo-3,4,10,10a-tetrahydro-1H-pyrazino[1,2-a]indol-2-yl)-cyclobutanone; treating disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, obesity and sleep apnea
08/07/2007US7253199 Azole derivatives and pharmaceutical compositions containing them
08/07/2007US7253194 Compounds and inhibitors of phospholipases
08/07/2007US7253191 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
08/07/2007US7253189 1-aminoindane derivatives, e.g., 1-(cyclopentylcarbonylamino)-5-(4-cyclopropyl-2-(phenylsulfonyl)phenylsulfonyl)indane; exhibit anti-inflammatory and immunomodulatory activity
08/07/2007US7253174 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis.
08/07/2007US7253171 Antiinflammatory agents; immunology diseases; multiple sclerosis; antihistamines; antidiabetic agents; vision defects; antiarthritic agents; skin disorders; antitumor agents
08/07/2007US7253167 Tricyclic-heteroaryl compounds useful as kinase inhibitors
08/07/2007US7253155 Combination of a tetra-substituted pyrimidopyrimidine, and a corticosteroid simultaneously or within 14 days of each other
08/07/2007US7252845 Synergistic compositions containing aromatic compounds and terpenoids present in Alpinia galanga
08/07/2007US7252799 Methods for sterilizing preparations containing albumin
08/07/2007CA2376379C Modified chimeric polypeptides with improved pharmacokinetic properties
08/07/2007CA2340636C Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents
08/07/2007CA2207804C Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor
08/07/2007CA2092718C Use of protective agents against reactive oxygen species
08/02/2007WO2007087524A2 Treatment of acute respiratory distress syndrome
08/02/2007WO2007087448A1 Spiro imidazole derivatives as ppar modulators
08/02/2007WO2007087215A2 N-acetyl-cysteine and its derivatives as an antitussive
08/02/2007WO2007086584A1 NOVEL INHIBITOR OF FabK AND FabI/K
08/02/2007WO2007086573A1 Agent for preventing or improving disease caused by candida infection and oral composition
08/02/2007WO2007086554A1 Tropane compound and pharmaceutical composition containing the same as active ingredient
08/02/2007WO2007076127A3 Condensed imidazoles or pyrazoles and their use as transforming growth factor modulators
08/02/2007WO2007059905A3 Thienopyrimidines treating inflammatory diseases
08/02/2007WO2007056181A3 Process for the preparation of ciclesonide
08/02/2007WO2007052073A3 Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors
08/02/2007US20070179297 Chemical compounds
08/02/2007US20070179184 Novel m3 muscarinic acetylcholine receptor antagonists
08/02/2007US20070179180 Novel m3 muscarinic acetylcholine receptor antagonists
08/02/2007US20070179179 respiratory diseases such as asthma, chronic obstructive pulmonary disease, bronchitis; useful in the treatment of nervous system injury and premature labor; 1-{2-[N-2-(4-hydroxy-3-formylaminophenyl)-2-(RS) hydroxyethyl]aminoethyl}-4-[N-(2-phenyl-2-(RS)-hydroxyethyl)amino]phenyl; milveterol
08/02/2007US20070179124 Substituted Porphyrins
08/02/2007US20070179101 biodrug as antitumor agent, a vaccine adjuvant for infections and cancers, and antiallergy agents